Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS · Delayed Price · Currency is USD
9.45
-0.18 (-1.87%)
Nov 13, 2025, 4:00 PM EST
Cipher Pharmaceuticals Revenue
Cipher Pharmaceuticals had revenue of $12.83M in the quarter ending September 30, 2025, with 23.75% growth. This brings the company's revenue in the last twelve months to $50.06M, up 89.17% year-over-year. In the year 2024, Cipher Pharmaceuticals had annual revenue of $33.36M with 57.66% growth.
Revenue (ttm)
50.06M
Revenue Growth
+89.17%
P/S Ratio
4.81
Revenue / Employee
10.01M
Employees
5
Market Cap
240.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.36M | 12.20M | 57.66% |
| Dec 31, 2023 | 21.16M | 487.00K | 2.36% |
| Dec 31, 2022 | 20.68M | -1.27M | -5.78% |
| Dec 31, 2021 | 21.94M | 336.00K | 1.56% |
| Dec 31, 2020 | 21.61M | -844.00K | -3.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| Nuo Therapeutics | 2.61M |
Cipher Pharmaceuticals News
- 6 days ago - Cipher Pharmaceuticals Inc (CPHRF) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 6 days ago - Q3 2025 Cipher Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
- 6 days ago - Cipher Pharmaceuticals Inc. (CPH:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - CIPHER PHARMACEUTICALS INC Profit Climbs In Q3, Beats Estimates - Nasdaq
- 5 weeks ago - Halvio Capital Q3 2025 Position Updates - Seeking Alpha
- 3 months ago - Cipher Pharmaceuticals Inc. (CPHRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue - Benzinga
- 6 months ago - Cipher Pharmaceuticals Inc. (CPHRF) Q1 2025 Earnings Call Transcript - Seeking Alpha